Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.

This open-label observational study found that ibogaine treatment of patients with opioid use disorder can induce a clinically relevant but reversible QTc prolongation, bradycardia, and severe ataxia.